Johnson & Johnson Financial Ratios
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Johnson & Johnson ratio analysis
Johnson & Johnson earned a net margin of 28.5% in FY 2025, up from 15.8% a year earlier. Gross margin was 67.9% compared with a median of 68.8% over the prior 9 years. Return on equity reached 32.9%, meaning Johnson & Johnson generated 0.33 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.59 versus 0.51 the year before, and the current ratio was 1.03. At the end of FY 2025, JNJ traded at 18.8 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 11.4 to 297.3, with a median of 23.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Johnson & Johnson financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 18.82 | 25.05 | 11.42 | 26.25 | 21.90 | 28.56 | 25.89 | 22.69 | 297.28 | 19.43 |
| Price / sales | 5.31 | 3.93 | 4.66 | 5.80 | 5.72 | 5.02 | 4.70 | 4.18 | 4.92 | 4.39 |
| Price / book | 6.13 | 4.88 | 5.77 | 6.04 | 6.08 | 6.55 | 6.48 | 5.71 | 6.25 | 4.48 |
| Gross margin | 67.9% | 69.1% | 68.8% | 69.3% | 70.3% | 65.6% | 66.4% | 66.8% | 66.7% | 69.7% |
| Net margin | 28.5% | 15.8% | 41.3% | 22.4% | 26.5% | 17.8% | 18.4% | 18.8% | 1.7% | 23.0% |
| Free cash flow margin | 20.9% | 22.3% | 21.4% | 21.5% | 25.1% | 24.4% | 24.3% | 22.7% | 23.3% | 21.6% |
| Return on equity (ROE) | 32.9% | 19.7% | 51.1% | 23.4% | 28.2% | 23.3% | 25.4% | 25.6% | 2.2% | 23.5% |
| Return on assets (ROA) | 13.5% | 7.8% | 21.0% | 9.6% | 11.5% | 8.4% | 9.6% | 10.0% | 0.8% | 11.7% |
| Debt / equity | 0.59 | 0.51 | 0.43 | 0.52 | 0.46 | 0.56 | 0.47 | 0.51 | 0.57 | 0.39 |
| Current ratio | 1.03 | 1.11 | 1.16 | 0.99 | 1.35 | 1.21 | 1.26 | 1.47 | 1.41 | 2.47 |
| Revenue growth | 6.0% | 4.3% | 6.5% | 1.6% | -4.7% | 0.6% | 0.6% | 6.7% | 6.3% | 2.6% |
| EPS growth | 90.5% | -57.8% | 103.9% | -13.8% | 41.7% | -2.1% | 0.4% | 1,093.6% | -92.1% | 8.2% |